NETSCOUT Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Network Monitoring Leadership
The company is acknowledged for its market leadership, innovation, and customer-centric execution in network monitoring, performance assurance, and real-time visibility. SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to...
Delta Intelligent Building Technologies Receives the 2025 Global Integrated Smart Buildings Solutions Competitive Strategy Leadership Recognition
Frost & Sullivan honors the company for its leadership in technology integration, collaboration, and innovation across the smart buildings ecosystem SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that...
Diabolocom Receives Frost & Sullivan's 2026 European Technology Innovation Leadership for Excellence in AI-Driven Customer Experience Platforms
Recognition highlights Diabolocom's innovation leadership, sovereign cloud strategy, and customer-centric approach to secure, compliant, and sustainable software & AI for Customer Experience SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- Frost &...
Hughes Network Systems Receives Frost & Sullivan's 2025 North American Managed SD-WAN Services Customer Value Leadership Recognition for Excellence in Secure Hybrid Connectivity
The company is honored for delivering superior customer purchase and ownership experiences through advanced innovation, operational efficiency, and secure hybrid connectivity. SAN ANTONIO, Jan. 8, 2026 /PRNewswire/ -- Frost & Sullivan is pleased...
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and...
Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China
BEIJING, Dec. 29, 2025 /PRNewswire/ -- In 2025, the world is undergoing accelerated transformation amid rising turbulence and uncertainty. The interconnectedness between China's development and the global landscape continues to grow, with China...
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 /PRNewswire/ --...
T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II...
AZI Receives Investment Letter: CDIB Capital Intends to Invest $300 Million at a Comprehensive Price of $5 Per Share, Company's Financial Strength to Be Significantly Enhanced Upon Transaction Completion
BEIJING, Dec. 17, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (the "Company" or "Autozi") today announced that it has received an investment letter from CDIB Capital International Holdings Limited ("CDIB"). Pursuant...
MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine
The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that MEDEZE Group...